Edition:
United Kingdom

NantKwest Inc (NK.OQ)

NK.OQ on NASDAQ Stock Exchange Global Select Market

2.72USD
19 Oct 2018
Change (% chg)

$-0.05 (-1.81%)
Prev Close
$2.77
Open
$2.77
Day's High
$2.84
Day's Low
$2.71
Volume
38,737
Avg. Vol
53,520
52-wk High
$5.47
52-wk Low
$2.67

Chart for

About

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Its immuno-oncology NK platform has multiple modes to induce cell death against the tumor or... (more)

Overall

Beta: --
Market Cap(Mil.): $405.94
Shares Outstanding(Mil.): 79.44
Dividend: --
Yield (%): --

Financials

  NK.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -1.27 -- --
ROI: -34.84 0.21 14.27
ROE: -35.88 1.17 15.99

Earnings vs. Estimates